Fast Five Quiz: Heart Failure With Reduced Ejection Fraction (HFrEF) Treatment Optimization

Alanna Morris, MD; Michael Weber, MD

Disclosures

September 14, 2022

Heart failure is a significant clinical and public health concern that affects approximately 26 million people worldwide. Nearly, 50% of heart failure cases are heart failure with reduced ejection fraction (HFrEF). HFrEF, also referred to as systolic heart failure, arises when the left ventricular ejection fraction is ≤ 40% and is accompanied by progressive left ventricular dilatation and adverse cardiac remodeling. Following hospitalization for HFrEF, the 5-year mortality rate is as high as 75%, particularly among older adults. Treatment aims to address underlying and associated conditions to reduce morbidity and mortality and improve clinical outcomes.

How familiar are you with treatment optimization for HFrEF? Test your knowledge with this quick quiz.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....